INHIBITION OF RETROVIRAL PROTEASE ACTIVITY BY AN ASPARTYL PROTEINASE-INHIBITOR
INHIBITION OF RETROVIRAL PROTEASE ACTIVITY BY AN ASPARTYL PROTEINASE-INHIBITOR
复制标题
DOI:
10.1038/329654a0
复制
发表时间:
1987-10-15
期刊:
影响因子:
64.8
通讯作者:
YOSHINAKA, Y
中科院分区:
文献类型:
--
作者:
KATOH, I;YASUNAGA, T;YOSHINAKA, Y
Retrovirus protease is an enzyme that cleavesgagandgag-polprecursor polyproteins into the functional proteins of mature virus particles1,2. The correct processing of precursor polyproteins is necessary for the infectivity of virus particles:in vitromutagenesis which introduces deletions into the murine leukaemia virus genome produces a protease-defective virus of immature core form and lacking infectivity3,4. A therapeutic drug effective against disease caused by retrovirus proliferation could likewise interfere with virus maturation. The primary structure has so far been determined for the protease of avian myeloblastosis virus5, and of murine6, feline7and bovine8leukaemia viruses. Amino acid sequencing of the retrovirus proteases, either after their purification or from prediction from the nucleotide sequence, shows that they possess the Asp-Thr-Gly sequence characteristic of the aspartyl pro-teinases. In this report we show that retrovirus proteases belong to the aspartyl proteinase group and demonstrate an inhibition by the aspartyl proteinase-specific inhibitor, pepstatin A, on the activity of bovine leukaemia, Moloney murine leukaemia and human T-cell leukaemia virus proteases.